Xiaorui Zhang Selected Research

Xiaorui Zhang Research Topics

Disease

7	Neoplasms (Cancer) 02/2021 - 10/2011
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 06/2016
3	Cognitive Dysfunction 01/2020 - 01/2019
2	Inflammation (Inflammations) 11/2021 - 10/2017
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 01/2020
2	Body Weight (Weight, Body) 07/2020 - 10/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017 - 01/2017
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2022
1	Newborn Respiratory Distress Syndrome 12/2022
1	Leukemia 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Rheumatic Diseases (Rheumatism) 11/2021
1	Brain Ischemia (Cerebral Ischemia) 11/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2021
1	Rheumatoid Arthritis 11/2021
1	COVID-19 02/2021
1	Colorectal Neoplasms (Colorectal Cancer) 02/2021
1	Yang Deficiency (Xu, Yang) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2020
1	Obesity 07/2020
1	Dyspepsia (Indigestion) 01/2020
1	Necrosis 01/2019
1	Dysbiosis 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Primary Myelofibrosis (Myelosclerosis) 01/2019
1	Fever (Fevers) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Retinoblastoma (Glioblastoma, Retinal) 12/2017
1	Neoplasm Metastasis (Metastasis) 11/2017

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 02/2021 - 06/2016
4	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2021 - 10/2015
2	ApelinIBA 12/2022 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022 - 01/2017
2	fms-Like Tyrosine Kinase 3IBA 01/2022 - 12/2017
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 12/2017
2	Therapeutic UsesIBA 11/2021 - 01/2021
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 01/2020
2	Polysaccharides (Glycans)IBA 07/2020 - 10/2011
2	Liuwei Dihuang DecoctionIBA 01/2020 - 01/2019
2	CytokinesIBA 01/2019 - 01/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	venetoclaxIBA 01/2022
1	c-Mer Tyrosine KinaseIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	InterferonsIBA 02/2021
1	zukamu granulesIBA 02/2021
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2021
1	AntibodiesIBA 02/2021
1	Adenine FDA LinkGeneric 01/2021
1	RibonucleoproteinsIBA 01/2021
1	Galectin 1 (LGALS1)IBA 10/2020
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 07/2020
1	CholesterolIBA 07/2020
1	Inulin FDA Link 07/2020
1	Triglycerides (Triacylglycerol)IBA 07/2020
1	Fructans (Levans)IBA 07/2020
1	Hormones (Hormone)IBA 01/2020
1	Donepezil (Aricept)FDA LinkGeneric 01/2020
1	Cholinesterases (Cholinesterase)IBA 01/2020
1	GastrinsIBA 01/2020
1	massa medicata fermentataIBA 01/2020
1	MelatoninIBA 01/2020
1	Memantine (Namenda)FDA Link 01/2020
1	16S Ribosomal RNAIBA 01/2020
1	Ficusin (Psoralen)IBA 01/2019
1	SteroidsIBA 01/2019
1	OsteocalcinIBA 01/2019
1	Atorvastatin (Lipitor)FDA Link 01/2019
1	AntipyreticsIBA 01/2019
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2019
1	Fibronectins (Fibronectin)IBA 01/2019
1	CollagenIBA 01/2019
1	LignansIBA 01/2018
1	IsoenzymesIBA 01/2018
1	Plant ExtractsIBA 01/2018
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2018
1	CytochromesIBA 01/2018
1	Polo-Like Kinase 1IBA 12/2017
1	Pharmaceutical PreparationsIBA 12/2017
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 12/2017
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 12/2017
1	Tyrosine Kinase InhibitorsIBA 12/2017
1	Cyclin B1IBA 12/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2017
1	Epinephrine (Adrenaline)FDA LinkGeneric 11/2017
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	Interleukin-10 (Interleukin 10)IBA 10/2017
1	Mustard Gas (Sulfur Mustard)IBA 10/2017
1	Interleukin-6 (Interleukin 6)IBA 10/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2017
1	Insulin (Novolin)FDA Link 01/2017

Therapy/Procedure

2	Immunotherapy 02/2021 - 01/2017
2	Therapeutics 01/2021 - 12/2017
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 01/2020
1	Analgesia 11/2021
1	Immunomodulation 01/2019
1	Subcutaneous Injections 10/2017